Oxandrolone Sandoz

Quick links

Choose a section

Quick links to important sections

Advertisements

Oxandrolone Sandoz

Advertisements
Advertisements
Advertisements

Overview of Oxandrolone Sandoz

Property Description
Active Ingredient Oxandrolone (INN)
Form Oral tablets
Pharmacological Class Anabolic Androgenic Steroid (AAS)
General Therapeutic Purpose Promoting weight gain/Countering tissue wasting
Origin Synthetic derivative of testosterone

Oxandrolone Sandoz is a prescription medication whose active ingredient is Oxandrolone, which is classified as an anabolic androgenic steroid and is typically supplied in the form of oral tablets. This medicine, manufactured by Sandoz, is clinically recognized for its therapeutic utility in combating severe involuntary weight loss. The primary medical use of Oxandrolone is to promote weight gain and counteract the protein catabolism (tissue wasting) that often follows extensive surgery, severe trauma, or chronic infection.

This medication is also indicated for patients who struggle to maintain normal weight due to specific medical reasons, and is sometimes used to alleviate bone pain associated with osteoporosis. Medication function is to help restore muscle mass and overall body condition in compromised patients by stimulating anabolism.


The Chemical Composition and Class of Oxandrolone

The core substance, Oxandrolone (INN), is chemically recognized as a synthetic derivative of testosterone. Its structure includes a key modification at the 17^th carbon position, making it a 17alpha-alkylated steroid. This feature is essential for its stability and high oral bioavailability, allowing it to be administered effectively as an oral tablet rather than requiring injection.

This structure places it firmly within the anabolic androgenic steroid pharmacological class, a group of agents known for promoting protein synthesis and tissue growth. Oxandrolone is clinically recognized for exhibiting a high ratio of anabolic to androgenic activity. This high ratio is a significant factor in its medical use, allowing the drug to primarily promote tissue building with fewer associated effects on male characteristics compared to some other drugs in its class.

Advertisements

What side effects are possible with Oxandrolone Sandoz?

Possible Side Effects and Safety Information

Oxandrolone Sandoz, a synthetic androgen and anabolic steroid, is associated with a range of serious and clinically significant adverse effects documented in regulatory labeling. The most critical safety warnings concern severe hepatotoxicity. This includes reports of Peliosis Hepatis (blood-filled cysts in the liver and spleen), which can lead to life-threatening liver failure or hemorrhage, and the development of liver cell tumors (some fatal), particularly with prolonged, high-dose use. Cholestatic hepatitis and jaundice can also occur and necessitate drug discontinuation.


Key Adverse Reactions and Safety Considerations

System-Organ Class Serious or Clinically Significant Reactions
Hepatic Peliosis Hepatis, Liver Cell Tumors (some malignant), Cholestatic Jaundice, Necrosis.
Cardiovascular/Metabolic Adverse blood lipid changes (decreased HDL, increased LDL) associated with increased risk of atherosclerosis. Edema, which may lead to congestive heart failure.
Androgenic/Endocrine Virilization in Females (e.g., voice deepening, clitoral enlargement, hirsutism), some changes may be irreversible. Inhibition of testicular function, testicular atrophy, and priapism in males.
Growth/Development Premature closure of epiphyses in children, compromising final adult height. The risk is greatest in younger patients.

Safety Restrictions and Monitoring

The medication is strictly contraindicated for patients with known or suspected carcinoma of the prostate or male breast, female breast carcinoma with hypercalcemia, pregnancy, nephrosis, or hypercalcemia. Due to the hepatic risks, liver function tests must be monitored regularly. In children, bone age must be assessed every six months by x-ray. Women should be observed for signs of virilization, and the drug should be discontinued immediately if such signs are evident to prevent potentially irreversible effects. Oxandrolone is classified as a Schedule III Controlled Substance due to the potential for abuse and dependence.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose scope

Classification Official Regulatory Statements
Documented Manifestations Officially documented information states that no specific symptoms or signs associated with overdosage have been reported.
Physiological Effects It is formally documented that sodium and water retention may occur following overdosage.
Antidote Status No specific antidote is known for Oxandrolone overdose.

Emergency Actions and Management

Action Required Official Regulatory Guidance
When to seek help Immediately call emergency services if the person has collapsed, is having a seizure, has trouble breathing, or cannot be awakened. Contact a poison control center immediately in case of suspected overdose.
Procedural Steps Management should consist of symptomatic and supportive treatment. Gastric lavage may be used as an intervention.

Connection to the Overall Overdose Profile

The regulatory documents define the acute overdose profile by noting the absence of reported specific signs. This necessitates that management relies on symptomatic and supportive treatment, consistent with the statement that no specific antidote is known. The mandatory help-seeking condition is dictated by the presence of general severe, life-threatening symptoms, directing immediate contact with emergency services or a poison control center in line with official health authority guidance.

Advertisements

Therapeutic Uses of Oxandrolone Sandoz

What Oxandrolone Sandoz Treats: Main Uses and Benefits

The therapeutic application of Oxandrolone Sandoz is commonly used for managing conditions characterized by addressing the consequences of severe tissue loss across several clinical contexts.

Oxandrolone Sandoz is commonly used to help with conditions characterized by periods of severe involuntary weight loss and systemic tissue wasting. It is primarily applied across domains where additional support is needed to address the resulting severe tissue wasting that follows major stressors.

The medicine is considered relevant for patients recovering from extensive surgery or severe trauma, including major burns, and for those with chronic infections leading to muscle loss. It is also considered for the management of bone pain associated with osteoporosis and to positively influence growth patterns in children with conditions like Turner Syndrome.

“The primary purpose is to support weight gain and the restoration of lean body mass.”

The primary purpose is to support weight gain and the restoration of lean body mass, which can contribute to easing the overall symptom load related to physical strain during recovery. It may be part of symptomatic management to ease the overall symptom burden of bone pain and provides support during difficult developmental episodes by easing physical strain.


Quick Fact: Relief for Bone Pain and Support for Lean Body Mass

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility for Oxandrolone Sandoz: Official Regulatory Profile

The eligibility for Oxandrolone is strictly defined by regulatory authorities based on specific contraindications and patient characteristics.

Category Regulatory Status
Populations for whom use is Contraindicated Males with known or suspected prostate or male breast carcinoma; Females with breast carcinoma and hypercalcemia; all individuals with nephrosis or hypercalcemia; individuals who are pregnant (Category X).
Age-related Eligibility Rules Pediatric Use is permitted but requires close monitoring via bone age X-rays every six months to prevent premature epiphyseal closure. Older Adults may be at increased risk for prostatic conditions and fluid retention.
Conditional Use Populations Use requires caution in patients with pre-existing cardiac, renal, or hepatic disease due to the documented risk of edema. Women must be monitored for signs of virilization, requiring drug discontinuation upon first evidence of mild changes.
Pregnancy and Lactation Contraindicated in pregnancy due to the risk of fetal masculinization. For lactating mothers, the label requires a decision to discontinue nursing or discontinue the drug.

These official statements define who may use the medicine as an adjunctive therapy, while mandating absolute exclusion for populations with certain malignancies, metabolic conditions, and pregnant individuals.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Oxandrolone (the active ingredient in Oxandrolone Sandoz) has officially documented interaction patterns primarily concerning its effect on the metabolism and pharmacodynamic outcomes of co-administered medicines, as detailed in government regulatory labeling.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Product Category Official Interaction Outcome (Regulatory Description)
Oral Anticoagulants (e.g., Warfarin) Co-administration increases sensitivity to the anticoagulant. This is quantified by regulatory documents as an increase in the anticoagulant’s AUC and half-life, which may result in unexpectedly large increases in PT/INR levels.
Oral Hypoglycemic Agents Oxandrolone may inhibit the metabolism of these agents.
Adrenal Cortical Steroids or ACTH Concomitant use may increase edema (fluid retention). This additive effect is specifically noted as a concern in patients with pre-existing cardiac, renal, or hepatic disease.
Cyclosporine May increase the risk or severity of liver damage (hepatotoxicity) when combined.

Regulatory Constraints and Monitoring

The interaction with oral anticoagulants like warfarin requires procedural restrictions: patients must undergo close monitoring of INR/PT levels, and the anticoagulant dosage must be adjusted when Oxandrolone treatment is initiated, changed, or discontinued. No specific timing separation requirements are formally mandated in the regulatory documents for the administration of Oxandrolone and other drugs.

Advertisements

Mechanism of Action

Oxandrolone is a synthetic analog of testosterone, structurally classified as an anabolic androgenic steroid. Its primary biological target is the Androgen Receptor (AR), a nuclear receptor found in various tissues, including skeletal muscle, bone, and adipose tissue. Oxandrolone functions as a potent agonist for the AR.

Upon binding, the drug-receptor complex undergoes nuclear translocation and then interacts with specific Androgen Response Elements (AREs) in the promoter regions of target genes. This molecular interaction modulates the transcription of genes, primarily increasing the expression of those involved in protein synthesis and decreasing those associated with protein catabolism.

Intracellularly, this transcriptional modulation shifts the net protein balance toward anabolism, particularly in skeletal muscle. System-level physiological consequences include modulation of nitrogen retention and an increase in lean body mass accretion. Furthermore, oxandrolone has been shown to modulate the circulating concentrations of certain lipids and gonadotropins, such as Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), via negative feedback at the pituitary axis.

Advertisements

Dosage and Administration Information

Oxandrolone is an anabolic androgenic steroid administered exclusively via the oral route as a tablet, supplied in 2.5 mg and 10 mg strengths. The official administration protocol is defined by short, intermittent cycles, as the medicine is not intended for continuous, long-term use.

The duration of a single course of therapy is typically two to four weeks, which may be repeated intermittently based on individual response. The total daily dosage for adults ranges from 2.5 mg to 20 mg and must be taken in two to four divided doses to distribute administration throughout the day.


Patient Population Official Dosing Rule
Adults Daily dosage of 2.5 mg to 20 mg in divided doses.
Pediatric Patients Maximum daily dosage is 0.1 mg/kg of body weight.
Older Adults A lower regimen, such as 5 mg taken twice daily, is often recommended.

If an administration time is missed, the dose should be taken immediately upon remembering. However, if it is nearly time for the next scheduled dose, the missed dose must be skipped to maintain the regular schedule, and a double dose is not to be taken. This procedural structure ensures that the total daily dosage remains within the label-based limits and adheres to the pattern of intermittent administration.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 2 and Phase 3 Trials

Clinical research has explored whether Oxandrolone is associated with changes in symptoms related to catabolic wasting states, such as those following extensive surgery, severe trauma, or chronic infections. Studies included evaluations of the compound's potential interaction with key neural pathways and its influence on protein metabolism.

Key studies have focused on patient groups experiencing weight loss or involuntary muscle wasting. The primary endpoints in these trials typically included the assessment of change in lean body mass (LBM) and change in total body weight measures over the initial treatment period.

Study Outcome Measures

In studies involving older men, oxandrolone treatment was associated with short-term increases in LBM and muscle strength, as well as a reduction in total body fat, compared to placebo. However, the gains in LBM and strength were not always maintained after discontinuation of the treatment, while the reduction in fat mass was largely sustained.

In pediatric patients recovering from severe burn injuries, randomized trials have assessed oxandrolone as an adjunct to nutritional support. Findings suggest the compound may be associated with improved wound healing and a faster rate of weight gain and restoration of LBM during the recovery phase.

Population Studied

Oxandrolone has been evaluated in adults and children for different indications. Research in older male subjects focused on changes in body composition and metabolic markers. The studies did not include data on pediatric or geriatric populations across all approved indications, and caution is required when evaluating findings outside the specific studied groups. Further research is ongoing to establish long-term safety and efficacy across diverse populations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Oxandrolone Sandoz (FAQ)


Q: Is Oxandrolone Sandoz the same type of medicine as other steroids?

Oxandrolone is chemically classified as an anabolic androgenic steroid (AAS). This means it is a synthetic derivative of the male hormone testosterone, intended to promote tissue building (anabolism).

It belongs to the anabolic steroid drug class and is distinct from other types of steroids, such as corticosteroids, which are used to reduce inflammation.


Q: Can Oxandrolone Sandoz affect liver function?

Official safety information notes that this medication is associated with a risk of severe hepatotoxicity (liver damage). This includes reports of rare but serious conditions like Peliosis Hepatis and liver cell tumors.

Due to these risks, regular monitoring of liver function tests is generally required during therapy.


Q: Are changes in mood a common side effect of Oxandrolone Sandoz?

Central nervous system (CNS) adverse reactions noted in regulatory labeling include emotional changes. These can include habituation, excitation, depression, and changes in libido (sex drive).


Q: Does Oxandrolone Sandoz cause hair loss in men or women?

In women, signs of virilization (development of male characteristics) are a documented risk. These effects include hirsutism (excessive hair growth) and male pattern baldness (hair loss).


Q: Can Oxandrolone Sandoz affect cholesterol levels?

Official labeling warns of adverse blood lipid changes. Specifically, this is described as a decrease in High-Density Lipoproteins (HDL) and sometimes an increase in Low-Density Lipoproteins (LDL).

These changes in blood fats are noted to be associated with an increased risk of hardening of the arteries (atherosclerosis).


Q: Does Oxandrolone Sandoz cause acne or skin changes?

Acne is listed in regulatory documents as a potential adverse reaction, particularly in women and young males who have not reached puberty.

For females, the development of acne is also considered one of the signs of virilization.


Q: What kind of research exists regarding Oxandrolone Sandoz and bone density?

The medication is sometimes prescribed to alleviate bone pain associated with osteoporosis, which is a condition related to bone structure and density. For children using the medication, regulatory documents mandate that bone age must be checked every six months to monitor bone development.


Q: What evidence exists for its use in patients with HIV-related wasting?

Official regulatory documents indicate that Oxandrolone can be used as an adjunctive therapy (alongside other treatments) to promote weight gain following chronic infections.

In the United States, the drug received a specific designation for its use in treating HIV-associated wasting syndrome.


Q: What is the half-life of Oxandrolone, and what does that mean for the patient?

The half-life of the active ingredient, Oxandrolone, is approximately 8 hours. The half-life is the time it takes for the body to reduce the amount of drug by half.

This pharmacokinetic characteristic is related to the administration schedule, which is defined as two to four divided doses daily to help maintain the drug's presence in the body.


Q: Why are anabolic steroids sometimes described as having a risk of misuse?

Oxandrolone is classified by regulatory bodies as a Schedule III Controlled Substance.

This classification is due to the documented potential for abuse and dependence, which is a formal regulatory classification for this class of medicine.


Q: Can a vegetarian or vegan patient take this medicine (capsule ingredients)?

The active ingredient is Oxandrolone. However, the inactive ingredients listed on one regulatory label for the tablet include lactose.

Lactose is derived from milk, and its presence is noted for those with dietary restrictions.


Q: Is Oxandrolone Sandoz known to cause weight gain that is not muscle?

The medicine is intended to increase lean body mass. However, one potential adverse reaction noted in the regulatory documents is edema (fluid retention).

This fluid retention can contribute to weight gain that is not muscle mass.


Q: Why is Oxandrolone Sandoz used for people with wasting conditions?

The medication is an Androgen Receptor agonist that works at a molecular level to stimulate protein synthesis and counteract protein catabolism (tissue breakdown).

This action shifts the body's net protein balance toward anabolism (tissue building), helping patients with involuntary weight loss restore muscle mass and overall body condition.


Q: Does taking Oxandrolone Sandoz require frequent blood tests or monitoring?

Yes, official safety information mandates regular monitoring. Due to the hepatic (liver) risks, liver function tests must be performed regularly.

For children, an assessment of bone age via X-ray is required every six months to check for premature bone development.


Q: Is it normal to feel more energized when starting this medicine?

The regulatory label lists excitation as a potential adverse reaction affecting the central nervous system (CNS).

If a patient experiences feeling more energized, this could be related to this documented CNS effect.


Q: Is there a limit to how long a person can stay on Oxandrolone Sandoz therapy?

Therapy is specifically intended for intermittent use and is not approved for continuous, long-term administration.

Regulatory documents describe a typical course of therapy as being for two to four weeks, which may be repeated intermittently if a doctor determines it is necessary.


Q: What are the ingredients in the tablet other than the active substance?

The active substance is Oxandrolone. The other components are known as inactive ingredients or excipients.

One regulatory label lists the inactive ingredients as cornstarch, lactose, magnesium stearate, and hydroxypropyl methylcellulose.


Q: Can people with high blood pressure take Oxandrolone Sandoz?

Use requires caution in patients with pre-existing cardiac (heart) disease due to the documented risk of edema (fluid retention).

Therefore, the documented risk of edema requires caution in patients with pre-existing cardiac disease due to the potential for fluid retention.


Q: Are patients required to stop drinking alcohol while taking this medicine?

The medicine carries a risk of severe hepatotoxicity (liver damage).

Because alcohol is also a substance known to affect the liver, co-administration with other hepatotoxic substances, such as alcohol, would generally be considered to heighten this risk.


Q: Does Oxandrolone Sandoz show up on typical drug tests?

Oxandrolone is listed as an exogenous anabolic androgenic steroid (AAS) on the World Anti-Doping Agency (WADA) Prohibited List.

This classification confirms that the substance is detectable via standard drug testing protocols.


Q: What is the difference in formulation between Sandoz Oxandrolone and a generic version?

Regulatory principles require generic and brand-name versions of a drug to contain the same active ingredient, strength, and dosage form.

However, the inactive ingredients (excipients), such as fillers or colorants, may vary between the Sandoz product and other generic equivalents.


Q: Does Oxandrolone Sandoz interact with thyroid medications?

Yes. The regulatory label notes that co-administration with thyroid hormone replacement therapy may cause a transient decrease in thyroid hormone replacement requirements.

Due to this potential effect, regulatory information mandates the clinical and laboratory monitoring of thyroid function.


Q: Are muscle cramps a potential side effect of Oxandrolone Sandoz?

Yes, muscle cramps are listed among the reported side effects in patient information sources derived from clinical experience with the drug.


Q: Can taking Oxandrolone Sandoz affect sleep patterns?

Yes. Adverse reactions noted on the regulatory label that affect the central nervous system (CNS) include insomnia, which is defined as difficulty falling or staying asleep.


Advertisements

How should Oxandrolone Sandoz be stored and disposed of?

Oxandrolone tablets must be stored according to official regulatory specifications to maintain product integrity and safety.

Storage Requirements

The medication must be stored at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed and protected from both excessive heat and excessive moisture (e.g., storage in a bathroom is prohibited). To prevent accidental ingestion, this Schedule III medicine must be secured out of the sight and reach of children by using the locked safety cap and placing it in a location that is up and away from access.

Disposal Instructions

Official guidelines recommend disposing of unused or expired Oxandrolone tablets through a drug take-back program or using a prepaid mail-back envelope. If these methods are unavailable, the medicine is not on the list for flushing and should be mixed with an undesirable substance (such as dirt or coffee grounds), placed in a sealed container, and thrown into the household trash. All personal information must be scratched out from the label before disposal of the packaging.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxandrolone Sandoz found in:

A-Z Index: